Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  • Home
  • Newsroom
  • Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU - Axcellant

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  1. sty 31, 2023

From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS).

Patrycja Buczak-Kula

CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical Trials Directive or under the new Clinical Trials Regulation (CTR), which entered into application on 31 January 2022.

https://www.ema.europa.eu/en/news/use-clinical-trials-information-system-becomes-mandatory-new-clinical-trial-applications-eu

Read more

Meet Axcellant at EANM 2024 in Hamburg

Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October…

We are delighted to share exciting news from our team at Axcellant!

Marking a significant achievement in our ongoing efforts to advance medical device research, we have successfully concluded a PMCF study…

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…